Xponance, Inc. Revolution Medicines, Inc. Transaction History
Xponance, Inc.
- $10.7 Billion
- Q4 2024
A detailed history of Xponance, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 12,127 shares of RVMD stock, worth $501,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,127
Previous 9,987
21.43%
Holding current value
$501,330
Previous $452,000
17.26%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RVMD
# of Institutions
299Shares Held
179MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$707 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$554 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$548 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$447 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$392 Million0.22% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.63B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...